The team at Central Hospital in Nancy, France is conducting research utilizing dental stem cells to regrow and restore bone density. The trial aims to direct dental mesenchymal stem cells to differentiate into engineered osteoblasts, as well as promoting angiogenesis, which is necessary given that bones typically lack sufficient vascularization to make efficient repairs. The benefit of using autologous [the patient’s own] stem cells makes this an effective treatment option that does not pose a risk of rejection. By directing stem cells to promote bone mineralization and endothelial growth, as well as creating vascularization to promote healing, stem cells can be applied to a variety of bone trauma and deficiencies.
This study will obtain dental pulp from the participants’ extracted wisdom teeth and culture the cells to promote differentiation into the osteoblasts. The patients will range from ages 13-17, and the study will begin recruiting participants soon.
As regenerative engineering progresses, we believe the best stem cells to use in emerging treatments will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor. To learn more about banking your own valuable stem cells to insure your family’s future health, visit StemSave or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.